Join our Newsletter
Browse by Category
-
Most Read This Week
- Study shows vitamin C kills drug-resistant strands of TB
- Agenus initiates enrollment in brain tumor vaccine trial
- Expert doubts CDC promotion of influenza vaccine
- SARS-like coronavirus possibly found in New York
- Vical Incorporated announces results of herpes vaccine trial
- Swine-origin flu variant cases continue in U.S.
- Scientist map critical portion of anti-influenza antibody
- Boy dies from superbug infection at NIH hospital
- Progress made on new TB drug
Tags
Africa AIDS anthrax Avian flu Canada Cancer CDC Centers for Disease Control chicken pox China cholera Dengue fever Detection technology Ebola H1N1 H5N1 Hepatitis Hepatitis B HIV HPV Human papillomavirus immunization India Infectious disease Influenza Malaria Maryland Measles Medical Countermeasures meningitis MRSA Mumps News Pertussis pneumonia polio Preparedness research rotavirus Tuberculosis vaccine development West Nile virus whooping cough World Health Organization Yellow Fever
Tag Archives: research
TSRI announces appointment of Patapoutian as HHMI investigator
TweetThe Scripps Research Institute, a La Jolla, California-based biomedical science research organization, recently announced that a professor in the organization’s Dorris Neuroscience Center has been named a Howard Hughes Medical Institute investigator. Ardem Patapoutian was one of 26 biomedical researchers … Read More »
Monkey model developed by NIH scientists to research coronavirus infection
TweetNational Institutes of Health researchers recently created a type of infection in rhesus macaques that will help other scientists better understand an emerging coronavirus. The coronavirus was first identified in September 2012 and has been known to affect people. The … Read More »
Certain bacteria may suppress toxic shock toxin
Tweet Canadian scientists discovered that certain lactobacillus bacteria are able to suppress the production of toxic shock syndrome toxin 1, demonstrating potential probiotic potential, according to a recent study. Certain Streptococci can increase their production of the toxin to potentially … Read More »
Arrowhead reduces 90 percent of hepatitis B antigens in chimpanzee study
TweetArrowhead Research Corporation, a Pasadena, California-based targeted therapeutics company, recently announced a preclinical chimpanzee study that demonstrated the success of its RNA interference-based hepatitis B virus therapeutic. ARC-520 is a hepatitis B antiviral candidate that works using a gene silencing … Read More »
Researcher poses hypothesis for antibiotic-resistant bacteria
Tweet A researcher from the University of Granada recently formulated a new hypothesis that non-resistant bacteria accidentally become resistant to antibiotics because they take up the DNA of resistant bacteria during antibiotic use. Mohammed Bakkali, a scientist in the Genetics … Read More »
Emergent BioSolutions’ CEO recognized as outstanding international business leader
ROCKVILLE, Md. Read More »
Battelle, IBM, Merck join university in plan for vaccine factory
An ambitious plan to build a vaccine factory in the Pittsburgh area is gaining momentum with the announcement March 11 of three new partners in the University of Pittsburgh Medical Center project, the Pittsburgh Business Times reported. Read More »